| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1035288B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0135288 |
| P932 | PMC publication ID | 4583459 |
| P698 | PubMed publication ID | 26407080 |
| P5875 | ResearchGate publication ID | 282243669 |
| P2093 | author name string | Shyam S Mohapatra | |
| Subhra Mohapatra | |||
| Weidong Xu | |||
| Sandhya Boyapalle | |||
| Payal Raulji | |||
| P2860 | cites work | Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A | Q24563176 |
| Update on HIV in Western Europe | Q26853700 | ||
| Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design | Q27634018 | ||
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 | Q27644478 | ||
| Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | Q27663293 | ||
| Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys | Q33597744 | ||
| RNA-triggered gene silencing | Q33719435 | ||
| Generation of improved humanized mouse models for human infectious diseases | Q34135605 | ||
| Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. | Q34169244 | ||
| Chitosan as a novel nasal delivery system for vaccines | Q34343257 | ||
| Immune clearance of highly pathogenic SIV infection | Q34370314 | ||
| Detection of transmission clusters of HIV-1 subtype C over a 21-year period in Cape Town, South Africa | Q34428077 | ||
| Chitosans for gene delivery | Q34446170 | ||
| Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis | Q34468210 | ||
| Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention | Q34784522 | ||
| Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice. | Q35154146 | ||
| Antimicrobial action of water-soluble β-chitosan against clinical multi-drug resistant bacteria. | Q35585591 | ||
| Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. | Q35784905 | ||
| Nanotechnology Applications to HIV Vaccines and Microbicides | Q35890514 | ||
| Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion | Q36032477 | ||
| Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses | Q36693991 | ||
| Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model | Q36840299 | ||
| Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector | Q36890686 | ||
| Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice | Q36936058 | ||
| Vaginal microbicides and the prevention of HIV transmission | Q37063819 | ||
| Recent advances in humanized mice: accelerating the development of an HIV vaccine | Q37254480 | ||
| Topical microbicides to prevent HIV: clinical drug development challenges | Q37324508 | ||
| BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection | Q37390234 | ||
| Vaccine-induced CD8+ T cells control AIDS virus replication | Q37442789 | ||
| Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells | Q37567860 | ||
| HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice | Q37643772 | ||
| Antimicrobial properties of chitosan and mode of action: a state of the art review | Q37800602 | ||
| HIV and HLA class I: an evolving relationship | Q38045636 | ||
| Human immune responses and potential for vaccine assessment in humanized mice | Q38102807 | ||
| Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. | Q38346824 | ||
| Anti-HIV activities of novel synthetic peptide conjugated chitosan oligomers | Q39022149 | ||
| Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. | Q39145426 | ||
| Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery | Q39231430 | ||
| Epidemiology: Sexual transmission of HIV in Africa | Q39569812 | ||
| Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference | Q39684598 | ||
| Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery | Q39950729 | ||
| Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy | Q40173243 | ||
| Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition | Q40589914 | ||
| Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference | Q40695522 | ||
| Modulation of HIV-1 replication by RNA interference | Q40721798 | ||
| siRNA-directed inhibition of HIV-1 infection | Q40727988 | ||
| Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells | Q40735249 | ||
| HIV-1 epidemiology and circulating subtypes in the countryside of South Brazil | Q40800949 | ||
| DNA-polycation nanospheres as non-viral gene delivery vehicles | Q41008174 | ||
| Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. | Q44358015 | ||
| Inhibition of SARS-CoV replication by siRNA. | Q45206542 | ||
| Maxizymes and small hairpin-type RNAs that are driven by a tRNA promoter specifically cleave a chimeric gene associated with leukemia in vitro and in vivo | Q51806142 | ||
| Choosing CCR5 or Rev siRNA in HIV-1 | Q73064066 | ||
| Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability | Q77357203 | ||
| Formulation and evaluation of mucoadhesive microspheres of tenofovir disoproxil fumarate for intravaginal use | Q86611898 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0135288 | |
| P577 | publication date | 2015-09-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models | |
| P478 | volume | 10 |
| Q38810516 | Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases |
| Q59354566 | Current State of Microbicide Development |
| Q64120845 | Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems |
| Q38889573 | Polymers in the Delivery of siRNA for the Treatment of Virus Infections. |
Search more.